<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35558377</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2296-2360</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>10</Volume>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in pediatrics</Title>
          <ISOAbbreviation>Front Pediatr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pancreatogenic Diabetes in Children With Recurrent Acute and Chronic Pancreatitis: Risks, Screening, and Treatment (Mini-Review).</ArticleTitle>
        <Pagination>
          <StartPage>884668</StartPage>
          <MedlinePgn>884668</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">884668</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2022.884668</ELocationID>
        <Abstract>
          <AbstractText>Up to 9% of children with acute recurrent pancreatitis (ARP) or chronic pancreatitis have pancreatogenic diabetes mellitus (DM), and this risk likely increases as they age into adulthood. Risk factors for pancreatogenic DM in children vary depending on the clinical cohort but may include pancreatic atrophy, exocrine insufficiency, pancreatic calcifications, obesity/metabolic syndrome features, or autoimmune diseases. Knowledge regarding disease pathology is extrapolated nearly entirely from studies in adults. Insulin deficiency is the primary defect, resulting from islet loss associated with pancreatic fibrosis and cytokine-mediated β-cell dysfunction. Beta cell autoimmunity (type 1 diabetes) should also be considered as markers for this have been identified in a small subset of children with pancreatogenic DM. Hepatic insulin resistance, a deficient pancreatic polypeptide state, and dysfunctional incretin hormone response to a meal are all potential contributors in adults with pancreatogenic DM but their significance in pediatrics is yet unknown. Current guidelines recommend yearly screening for diabetes with fasting glucose and hemoglobin A1c (HbA1c). Insulin in the first-line pharmacologic therapy for treatment of pancreatogenic DM in children. Involvement of a multidisciplinary team including a pediatric endocrinologist, gastroenterologist, and dietitian are important, and nutritional health and exocrine insufficiency must also be addressed for optimal DM management.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Bellin.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bellin</LastName>
            <ForeName>Melena D</ForeName>
            <Initials>MD</Initials>
            <AffiliationInfo>
              <Affiliation>University of Minnesota Medical School and Masonic Children's Hospital, Minneapolis, MN, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Pediatr</MedlineTA>
        <NlmUniqueID>101615492</NlmUniqueID>
        <ISSNLinking>2296-2360</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">DM</Keyword>
        <Keyword MajorTopicYN="N">T3cD</Keyword>
        <Keyword MajorTopicYN="N">endocrine</Keyword>
        <Keyword MajorTopicYN="N">exocrine</Keyword>
        <Keyword MajorTopicYN="N">insulin</Keyword>
        <Keyword MajorTopicYN="N">islet</Keyword>
        <Keyword MajorTopicYN="N">pancreatic</Keyword>
      </KeywordList>
      <CoiStatement>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor VM declared a shared consortium, INSPPIRE consortium (International Study Group for Pediatric Pancreatitis - In Search for a Cure), with the author MB at the time of review.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>13</Day>
          <Hour>18</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35558377</ArticleId>
        <ArticleId IdType="pmc">PMC9086714</ArticleId>
        <ArticleId IdType="doi">10.3389/fped.2022.884668</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Perito E, Gonska T, Bellin MD, Schwarzenberg SJ. Complications of chronic pancreatitis in children.
Curr Opin Gastroenterol. (2021) 37:498–503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8364500</ArticleId>
            <ArticleId IdType="pubmed">34127575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uc A, Andersen DK, Apkarian AV, Bellin MD, Colloca L, Drewes AM, et al. 
Pancreatic pain-knowledge gaps and research opportunities in children and adults: summary of a National institute of diabetes and digestive and kidney diseases workshop.
Pancreas. (2021) 50:906–15. 10.1097/MPA.0000000000001899
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPA.0000000000001899</ArticleId>
            <ArticleId IdType="pubmed">34643606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellin MD, Lowe M, Zimmerman MB, Wilschanski M, Werlin S, Troendle DM, et al. 
Diabetes mellitus in children with acute recurrent and chronic pancreatitis: data From the INternational study group of pediatric pancreatitis: in search for a CuRE cohort.
J Pediatr Gastroenterol Nutr. (2019) 69:599–606. 10.1097/MPG.0000000000002482
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPG.0000000000002482</ArticleId>
            <ArticleId IdType="pmc">PMC6834233</ArticleId>
            <ArticleId IdType="pubmed">31651815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hart PA, Bellin MD, Andersen DK, Bradley D, Cruz-Monserrate Z, Forsmark CE, et al. 
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.
Lancet Gastroenterol Hepatol. (2016) 1:226–37. 10.1016/S2468-1253(16)30106-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2468-1253(16)30106-6</ArticleId>
            <ArticleId IdType="pmc">PMC5495015</ArticleId>
            <ArticleId IdType="pubmed">28404095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abu-El-Haija M, Hornung L, Denson LA, Husami A, Lin TK, Matlock K, et al. 
Prevalence of abnormal glucose metabolism in pediatric acute, acute recurrent and chronic pancreatitis.
PLoS One. (2018) 13:e0204979. 10.1371/journal.pone.0204979
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0204979</ArticleId>
            <ArticleId IdType="pmc">PMC6209152</ArticleId>
            <ArticleId IdType="pubmed">30379828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chowdhury SD, Chacko A, Ramakrishna BS, Dutta AK, Augustine J, Koshy AK, et al. 
Clinical profile and outcome of chronic pancreatitis in children.
Indian Pediatr. (2013) 50:1016–9. 10.1007/s13312-013-0281-z
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13312-013-0281-z</ArticleId>
            <ArticleId IdType="pubmed">23798627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwarzenberg SJ, Uc A, Zimmerman B, Wilschanski M, Wilcox CM, Whitcomb DC, et al. 
Chronic pancreatitis: pediatric and adult cohorts show similarities in disease progress despite different risk factors.
J Pediatr Gastroenterol Nutr. (2019) 68:566–73. 10.1097/MPG.0000000000002279
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPG.0000000000002279</ArticleId>
            <ArticleId IdType="pmc">PMC6492264</ArticleId>
            <ArticleId IdType="pubmed">30897605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention [CDC].
Diabetes Report Card 2019.
Atlanta, GA: Centers for Disease Control and Prevention;  (2020). Available from: https://www.cdc.gov/diabetes/library/reports/reportcard/diabetes-in-youth.html</Citation>
        </Reference>
        <Reference>
          <Citation>Sellers ZM, MacIsaac D, Yu H, Dehghan M, Zhang KY, Bensen R, et al. 
Nationwide trends in acute and chronic pancreatitis among privately insured children and non-elderly adults in the United States, 2007-2014.
Gastroenterology. (2018) 155:469–78.e1. 10.1053/j.gastro.2018.04.013
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2018.04.013</ArticleId>
            <ArticleId IdType="pmc">PMC6067969</ArticleId>
            <ArticleId IdType="pubmed">29660323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malka D, Hammel P, Sauvanet A, Rufat P, O’Toole D, Bardet P, et al. 
Risk factors for diabetes mellitus in chronic pancreatitis.
Gastroenterology. (2000) 119:1324–32. 10.1053/gast.2000.19286
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/gast.2000.19286</ArticleId>
            <ArticleId IdType="pubmed">11054391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellin MD, Whitcomb DC, Abberbock J, Sherman S, Sandhu BS, Gardner TB, et al. 
Patient and disease characteristics associated with the presence of diabetes mellitus in adults with chronic pancreatitis in the United States.
Am J Gastroenterol. (2017) 112:1457–65. 10.1038/ajg.2017.181
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ajg.2017.181</ArticleId>
            <ArticleId IdType="pmc">PMC6168293</ArticleId>
            <ArticleId IdType="pubmed">28741615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elliott IA, Epelboym I, Winner M, Allendorf JD, Haigh PI. Population-level incidence and predictors of surgically induced diabetes and exocrine insufficiency after partial pancreatic resection.
Perm J. (2017) 21:16–095. 10.7812/TPP/16-095
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7812/TPP/16-095</ArticleId>
            <ArticleId IdType="pmc">PMC5391783</ArticleId>
            <ArticleId IdType="pubmed">28406793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, et al. 
Clinical and genetic characteristics of hereditary pancreatitis in Europe.
Clin Gastroenterol Hepatol. (2004) 2:252–61. 10.1016/s1542-3565(04)00013-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1542-3565(04)00013-8</ArticleId>
            <ArticleId IdType="pubmed">15017610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellin MD, Schwarzenberg SJ, Cook M, Sutherland DE, Chinnakotla S. Pediatric autologous islet transplantation.
Curr Diabetes Rep. (2015) 15:67. 10.1007/s11892-015-0639-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11892-015-0639-9</ArticleId>
            <ArticleId IdType="pmc">PMC5536342</ArticleId>
            <ArticleId IdType="pubmed">26275441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schrader H, Menge BA, Zeidler C, Ritter PR, Tannapfel A, Uhl W, et al. 
Determinants of glucose control in patients with chronic pancreatitis.
Diabetologia. (2010) 53:1062–9. 10.1007/s00125-010-1705-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-010-1705-0</ArticleId>
            <ArticleId IdType="pubmed">20217037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nyboe Andersen B, Krarup T, Thorsgaard Pedersen NT, Faber OK, Hagen C, Worning H. B cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function.
Diabetologia. (1982) 23:86–9. 10.1007/BF01271165
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF01271165</ArticleId>
            <ArticleId IdType="pubmed">6182047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larsen S, Hilsted J, Tronier B, Worning H. Pancreatic hormone secretion in chronic pancreatitis without residual beta-cell function.
Acta Endocrinol. (1988) 118:357–64. 10.1530/acta.0.1180357
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/acta.0.1180357</ArticleId>
            <ArticleId IdType="pubmed">2899369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lundberg R, Beilman GJ, Dunn TB, Pruett TL, Freeman ML, Ptacek PE, et al. 
Early alterations in glycemic control and pancreatic endocrine function in nondiabetic patients with chronic pancreatitis.
Pancreas. (2016) 45:565–71. 10.1097/MPA.0000000000000491
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPA.0000000000000491</ArticleId>
            <ArticleId IdType="pmc">PMC4783201</ArticleId>
            <ArticleId IdType="pubmed">26918872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donowitz M, Hendler R, Spiro HM, Binder HJ, Felig P. Glucagon secretion in acute and chronic pancreatitis.
Ann Intern Med. (1975) 83:778–81. 10.7326/0003-4819-83-6-778
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7326/0003-4819-83-6-778</ArticleId>
            <ArticleId IdType="pubmed">1200523</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pavan Kumar P, Radhika G, Rao GV, Pradeep R, Subramanyam C, Talukdar R, et al. 
Interferon γ and glycemic status in diabetes associated with chronic pancreatitis.
Pancreatology. (2012) 12:65–70. 10.1016/j.pan.2011.12.005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pan.2011.12.005</ArticleId>
            <ArticleId IdType="pubmed">22487478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kharoud HK, Mettler T, Freeman ML, Trikudanathan G, Beilman GJ, Chinnakotla S, et al. 
Type 1 diabetes mellitus in patients with recurrent acute and chronic pancreatitis: a case series.
Pancreatology. (2021) 21:95–7. 10.1016/j.pan.2020.12.006
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pan.2020.12.006</ArticleId>
            <ArticleId IdType="pmc">PMC7856006</ArticleId>
            <ArticleId IdType="pubmed">33309625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yadav D, Whitcomb DC, Tang G, Slivka A, Bellin M. Autoimmunity may explain diabetes in a subset of patients with recurrent acute and chronic pancreatitis: a pilot study.
Clin Gastroenterol Hepatol. (2021). [Online ahead of print]. 10.1016/j.cgh.2021.11.011
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cgh.2021.11.011</ArticleId>
            <ArticleId IdType="pubmed">34793964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faerch K, Brøns C, Alibegovic AC, Vaag A. The disposition index: adjustment for peripheral vs. hepatic insulin sensitivity?.
J Physiol. (2010) 588:759–64. 10.1113/jphysiol.2009.184028
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.2009.184028</ArticleId>
            <ArticleId IdType="pmc">PMC2834935</ArticleId>
            <ArticleId IdType="pubmed">20100741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goodarzi MO, Nagpal T, Greer P, Cui J, Chen YI, Guo X, et al. 
Genetic risk score in diabetes associated with chronic pancreatitis versus type 2 diabetes mellitus.
Clin Transl Gastroenterol. (2019) 10:e00057. 10.14309/ctg.0000000000000057
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14309/ctg.0000000000000057</ArticleId>
            <ArticleId IdType="pmc">PMC6708663</ArticleId>
            <ArticleId IdType="pubmed">31232720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brunicardi FC, Chaiken RL, Ryan AS, Seymour NE, Hoffmann JA, Lebovitz HE, et al. 
Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis.
J Clin Endocrinol Metab. (1996) 81:3566–72. 10.1210/jcem.81.10.8855802
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jcem.81.10.8855802</ArticleId>
            <ArticleId IdType="pubmed">8855802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yki-Järvinen H, Kiviluoto T, Taskinen MR. Insulin resistance is a prominent feature of patients with pancreatogenic diabetes.
Metabolism. (1986) 35:718–27. 10.1016/0026-0495(86)90239-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0026-0495(86)90239-8</ArticleId>
            <ArticleId IdType="pubmed">3736412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar K, Sharma R, Manrai M, Sood AK. Visceral adipose tissue as a risk factor for diabetes mellitus in patients with chronic pancreatitis: a cross-sectional, observational study.
Diabetes Ther. (2017) 8:1057–64. 10.1007/s13300-017-0304-1
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13300-017-0304-1</ArticleId>
            <ArticleId IdType="pmc">PMC5630559</ArticleId>
            <ArticleId IdType="pubmed">28895079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aslam M, Vijayasarathy K, Talukdar R, Sasikala M, Nageshwar Reddy D. Reduced pancreatic polypeptide response is associated with early alteration of glycemic control in chronic pancreatitis.
Diabetes Res Clin Pract. (2020) 160:107993. 10.1016/j.diabres.2019.107993
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diabres.2019.107993</ArticleId>
            <ArticleId IdType="pubmed">31877344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qi L, Wei Q, Ni M, Liu D, Bao J, Lv Y, et al. 
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus.
Diabetes Metab. (2021) 48:101316. 10.1016/j.diabet.2021.101316
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diabet.2021.101316</ArticleId>
            <ArticleId IdType="pubmed">34929379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hart PA, Andersen DK, Mather KJ, Castonguay AC, Bajaj M, Bellin MD, et al. 
Evaluation of a mixed meal test for diagnosis and characterization of PancrEaTogEniC DiabeTes secondary to pancreatic cancer and chronic pancreatitis: rationale and methodology for the DETECT study from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer.
Pancreas. (2018) 47:1239–43. 10.1097/mpa.0000000000001168
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/mpa.0000000000001168</ArticleId>
            <ArticleId IdType="pmc">PMC6195331</ArticleId>
            <ArticleId IdType="pubmed">30325863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knop FK. Incretin hormones and beta cell function in chronic pancreatitis.
Dan Med Bull. (2010) 57:B4163. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20591345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knop FK, Vilsbøll T, Højberg PV, Larsen S, Madsbad S, Holst JJ, et al. 
The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.
Regul Pept. (2007) 144:123–30. 10.1016/j.regpep.2007.07.002
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.regpep.2007.07.002</ArticleId>
            <ArticleId IdType="pubmed">17692937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellin MD, Freeman ML, Gelrud A, Slivka A, Clavel A, Humar A, et al. 
Total pancreatectomy and islet autotransplantation in chronic pancreatitis: recommendations from PancreasFest.
Pancreatology. (2014) 14:27–35. 10.1016/j.pan.2013.10.009
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pan.2013.10.009</ArticleId>
            <ArticleId IdType="pmc">PMC4058640</ArticleId>
            <ArticleId IdType="pubmed">24555976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freeman AJ, Maqbool A, Bellin MD, Goldschneider KR, Grover AS, Hartzell C, et al. 
Medical management of chronic pancreatitis in children: a position paper by the North American Society for pediatric gastroenterology, hepatology, and nutrition pancreas committee.
J Pediatr Gastroenterol Nutr. (2021) 72:324–40. 10.1097/MPG.0000000000003001
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPG.0000000000003001</ArticleId>
            <ArticleId IdType="pmc">PMC8054312</ArticleId>
            <ArticleId IdType="pubmed">33230082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, et al. 
2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022.
Diabetes Care. (2022) 45:S17–38. 10.2337/dc22-S002
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/dc22-S002</ArticleId>
            <ArticleId IdType="pubmed">34964875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rickels MR, Bellin M, Toledo FG, Robertson RP, Andersen DK, Chari ST, et al. 
Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012.
Pancreatology. (2013) 13:336–42. 10.1016/j.pan.2013.05.002
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pan.2013.05.002</ArticleId>
            <ArticleId IdType="pmc">PMC3830751</ArticleId>
            <ArticleId IdType="pubmed">23890130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Consoli A, Formoso G. Potential side effects to GLP-1 agonists: understanding their safety and tolerability.
Expert Opin Drug Saf. (2015) 14:207–18. 10.1517/14740338.2015.987122
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/14740338.2015.987122</ArticleId>
            <ArticleId IdType="pubmed">25496749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crosby J, Bellin MD, Radosevich DM, Chinnakotla S, Dunn TB, Pruett TL, et al. 
Gastrointestinal symptoms before and after total pancreatectomy with islet autotransplantation: the role of pancreatic enzyme dosing and adherence.
Pancreas. (2015) 44:453–8. 10.1097/MPA.0000000000000266
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPA.0000000000000266</ArticleId>
            <ArticleId IdType="pmc">PMC4357567</ArticleId>
            <ArticleId IdType="pubmed">25486528</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
